Cancer vaccines for established cancer: how to make them better?
/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:242-55Strategies and challenges in eliciting immunity to melanoma
/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:28-42An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
/in HIV/AIDS, International Publications /von 2008-04-01 / J. Clin. Invest. 2008 Apr;118(4):1427-36Reengineering dendritic cell-based anti-cancer vaccines
/in Breast Cancer, International Publications /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:256-76Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
/in Glioblastoma, International Publications /von 2008-03-28 / Cancer Immunol. Immunother. 2008 Dec;57(12):1745-56Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
/in Chronic Leukemia, International Publications /von 2008-03-06 / Leukemia 2008 May;22(5):1007-17Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour
/in Glioblastoma, International Publications /von 2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-42Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
/in International Publications, Newcastle Disease Virus /von 2008-03-04 / J. Neuroimmunol. 2008 Mar;195(1-2):21-7IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de